Wells Fargo & Company Maia Biotechnology, Inc. Transaction History

Wells Fargo & Company

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.1 - $2.55 $24 - $56	22 Added 31.88%	91 $0
Q4 2023 Feb 09, 2024	BUY	$0.83 - $2.54 $4 - $15	6 Added 9.52%	69 $0
Q3 2023 Nov 13, 2023	BUY	$1.42 - $2.41 $41 - $69	29 Added 85.29%	63 $0
Q2 2023 Aug 15, 2023	BUY	$2.11 - $3.84 $42 - $76	20 Added 142.86%	34 $0
Q3 2022 Nov 14, 2022	BUY	$3.25 - $7.8 $45 - $109	14 New	14 $0

1.79M

Ticker MAIA
Exchange
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,935,900
Market Cap $29.6M
Description
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.